全球内视镜超音波市场规模依产品类型、应用、最终用户、地区、范围和预测

内视镜超音波市场规模及预测

2024 年内视镜超音波市场规模价值 11.8 亿美元，预计到 2032 年将达到 18.7 亿美元，2026 年至 2032 年的复合年增长率为 6.5%。

内视镜超音波(EUS) 是一种使用内视镜和超音波获取消化道及周围组织和器官的详细影像的医疗程序，为诊断和治疗目的提供高解析度影像。

超音波超音波广泛用于诊断和分期胃肠道（GI）癌症，包括食道癌、胰臟癌和大肠癌。

它也用于评估胰臟炎、胆结石、囊肿等良性疾病。 EUS 允许使用细针抽吸 (FNA) 获取组织样本进行切片检查，有助于准确诊断和治疗计划。

其他治疗应用包括胰臟假性囊肿引流、腹腔神经丛神经鬆弛以控制疼痛、以及引导注射和放置支架。

内视镜超音波的前景光明，预计技术进步将增强诊断和治疗能力。

全球内视镜超音波市场动态

关键市场驱动因素

胃肠道疾病盛行率不断上升：胃肠道癌症和其他胃肠道疾病盛行率的不断上升，推动了对内视镜超音波(EUS) 等先进诊断工具的需求，以便早期发现并改善治疗效果。根据美国国家癌症研究所的数据，大肠直肠癌是美国第三大常见癌症，预计2022年将新增151,030例。

技术进步：EUS 设备的持续创新，例如高解析度成像和微创技术，正在提高诊断准确性并扩大治疗应用范围，从而推动市场成长。美国食品药物管理局(FDA) 将在 2024 年核准12 种新型内视镜设备，与前一年同期比较成长 20%，凸显了该领域创新的快速步伐。

微创手术的普及率不断提升：由于人们更倾向于微创诊断和治疗手术，以缩短患者康復时间并降低相关风险，EUS 在临床实践中的应用正在加速。美国医疗保险和医疗补助服务中心 (CMS) 报告显示，从 2020 年到 2024 年，门诊内视镜手术数量将增加 15%，这反映了这一趋势。 EUS 手术可以缩短患者康復时间并降低相关风险，因此越来越受欢迎。

老年人口不断增长：全球人口老化将导致与老龄化相关的胃肠道疾病的盛行率上升，需要像EUS这样的先进诊断程序来有效管理和治疗。世界卫生组织（WHO）预测，2015年至2050年期间，全球60岁以上人口的比例将几乎翻一番，从12%增加到22%。预计这项人口结构变化将推动EUS的需求。

医疗保健支出成长：医疗保健支出成长，尤其是在发展中地区，将促进先进医疗技术的采用和普及，包括超音波内视镜（EUS），从而改善优质诊断和治疗服务的可近性。世界银行报告称，全球医疗保健支出占GDP的比例将从2010年的9.7%上升到2022年的10.2%，显示对医疗保健服务和科技的投资正在不断增长。这一趋势正在改善优质诊断和治疗服务的可近性。

主要挑战

缺乏训练有素的专业人员：EUS 程序的复杂性需要专门的培训和专业知识，而缺乏经过充分培训的专业人员可能会阻碍该技术的市场成长和广泛采用。

严格的监管要求：严格的核准流程和监管标准的遵守可能会减缓新的 EUS 设备和技术的引入，从而影响市场扩张和创新。

併发症和副作用的风险：儘管 EUS 是一种微创技术，但它确实存在感染、出血和穿孔等风险，这可能会阻止患者和提供者选择这种诊断程序。

来自替代成像方式的竞争：其他先进影像技术（如 MRI 和电脑断层扫描）的可用性，可有效诊断胃肠道疾病，可能会限制对 EUS 的需求并影响市场成长。

主要趋势

人工智慧 (AI) 的整合：将人工智慧和机器学习融入 EUS 系统，以增强影像分析和解读，提高诊断准确性和效率，并制定更精准、更个人化的治疗方案，这一趋势正在加速发展。美国国立卫生研究院 (NIH) 于 2024 年报告称，与传统方法相比，人工智慧辅助 EUS 诊断可将早期胰臟癌的检出率提高 15%。近期，Olympus Corporation于 2024 年 7 月 10 日宣布推出一款搭载人工智慧的全新 EUS 平台，预计将手术时间缩短 30%，并提高病变检出率。

设备小型化：EUS 探头和仪器体积越来越小，降低了操作的创伤性，并提高了患者的舒适度。欧洲胃肠内视镜学会 (ESGE) 于 2024 年报告称，过去五年内，EUS 探头的平均直径减小了 25%，显着降低了患者的不适感。这一趋势正在扩大 EUS 的应用范围，尤其是在门诊病人中。

扩大治疗应用：EUS 的应用范围不仅限于诊断，还日益广泛地应用于标靶药物、囊肿引流和肿瘤切除等治疗性介入，这正在扩大其临床效用，并推动市场成长。根据美国胃肠内视镜学会 (ASGE) 的报告，EUS 引导下的干预措施在 2019 年至 2024 年间将增加 40%，其中囊肿引流和肿瘤切除等手术的增幅最高。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章内视镜超音波市场（依产品类型）

• 放射状内超音波超音波检查（EUS）
• 线性内视镜超音波（EUS）
• 凸面内视镜超音波（EUS）
• 相位阵列超音波（EUS）
• 多普勒超音波超音波（EUS）

第五章内视镜超音波市场（依应用）

• 消化系统
• 肿瘤学
• 呼吸系统医疗设备
• 妇科
• 泌尿系统

第六章内视镜超音波市场（依最终用户）

• 医院
• 门诊手术中心（ASC）
• 诊断中心
• 诊所

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Olympus Corporation
• PENTAX Medical（HOYA Corporation）
• FUJIFILM Corporation
• Hitachi Medical Systems
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Endoscopy Ultrasound Market Size And Forecast

Endoscopy Ultrasound Market size was valued at USD 1.18 Billion in 2024 and is projected to reach USD 1.87 Billion by 2032, growing at a CAGR of 6.5% from 2026 to 2032.

Endoscopic ultrasound (EUS) is a medical procedure that uses an endoscope and ultrasound to obtain detailed images of the digestive tract and surrounding tissues and organs, providing high-resolution imaging for diagnostic and therapeutic purposes.

Endoscopic ultrasound is widely used in the diagnosis and staging of gastrointestinal (GI) cancers, such as esophageal, pancreatic, and colorectal cancers.

It is also employed to evaluate benign conditions like pancreatitis, gallstones, and cysts. EUS enables fine-needle aspiration (FNA) to obtain tissue samples for biopsy, aiding in accurate diagnosis and treatment planning.

Additionally, therapeutic applications include drainage of pancreatic pseudocysts, celiac plexus neurolysis for pain management, and guided injections or placements of stents.

The future of endoscopic ultrasound is promising due to anticipated technological advancements that will enhance its diagnostic and therapeutic capabilities.

Global Endoscopy Ultrasound Market Dynamics

The key market dynamics that are shaping the global endoscopy ultrasound market include:

Key Market Drivers

Increasing Prevalence of Gastrointestinal Diseases: The rising incidence of GI cancers and other digestive disorders drives demand for advanced diagnostic tools like endoscopic ultrasound (EUS) to improve early detection and treatment outcomes. According to the National Cancer Institute, colorectal cancer is the third most common cancer in the United States, with an estimated 151,030 new cases in 2022.

Technological Advancements: Continuous innovations in EUS equipment, such as high-resolution imaging and minimally invasive techniques, enhance diagnostic accuracy and broaden the range of therapeutic applications, boosting market growth. The U.S. Food and Drug Administration (FDA) approved 12 new endoscopic devices in 2024, a 20% increase from the previous year, highlighting the rapid pace of innovation in this field.

Growing Adoption of Minimally Invasive Procedures: The preference for minimally invasive diagnostic and therapeutic procedures, which reduce patient recovery time and associated risks, fuels the adoption of EUS in clinical settings. The Centers for Medicare & Medicaid Services reported a 15% increase in outpatient endoscopic procedures between 2020 and 2024, reflecting this trend. EUS procedures, which reduce patient recovery time and associated risks, are becoming increasingly popular.

Rising Geriatric Population: An aging global population increases the prevalence of age-related gastrointestinal conditions, necessitating advanced diagnostic procedures like EUS for effective management and treatment. The World Health Organization projects that the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. This demographic shift is expected to drive demand for EUS procedures.

Increasing Healthcare Expenditure: Higher healthcare spending, particularly in developing regions, supports the adoption and implementation of advanced medical technologies, including EUS, improving access to quality diagnostic and therapeutic services. The World Bank reported that global health expenditure as a percentage of GDP increased from 9.7% in 2010 to 10.2% in 2022, indicating growing investment in healthcare services and technologies. This trend is improving access to quality diagnostic and therapeutic services.

Key Challenges:

Limited Availability of Skilled Professionals: The complexity of EUS procedures necessitates specialized training and expertise, and the shortage of adequately trained professionals can hinder market growth and the widespread adoption of this technology.

Stringent Regulatory Requirements: The rigorous approval processes and compliance with strict regulatory standards can delay the introduction of new EUS devices and technologies, impacting market expansion and innovation.

Risk of Complications and Adverse Effects: Although minimally invasive, EUS procedures carry risks such as infection, bleeding, and perforation, which may deter patients and healthcare providers from opting for this diagnostic method.

Competition from Alternative Imaging Modalities: The availability of other advanced imaging technologies, such as MRI and CT scans, which are also effective in diagnosing GI conditions, can limit the demand for EUS, affecting market growth.

Key Trends

Integration of Artificial Intelligence (AI): AI and machine learning are being increasingly integrated into EUS systems to enhance image analysis and interpretation, improving diagnostic accuracy and efficiency, and enabling more precise and personalized treatment plans. The National Institutes of Health (NIH) reported in 2024 that AI-assisted EUS diagnoses showed a 15% improvement in early pancreatic cancer detection compared to traditional methods. In a recent development, on July 10, 2024, Olympus Corporation announced the launch of its new AI-powered EUS platform, promising a 30% reduction in procedure time and improved lesion detection rates.

Miniaturization of Equipment: Ongoing advancements in the miniaturization of EUS probes and devices are making procedures less invasive and more comfortable for patients, expanding the range of applications and facilitating adoption in outpatient settings. The European Society of Gastrointestinal Endoscopy (ESGE) reported in 2024 that the average diameter of EUS probes decreased by 25% over the past five years, significantly reducing patient discomfort. This trend has expanded the range of EUS applications, particularly in outpatient settings.

Expansion of Therapeutic Applications: Beyond diagnostics, EUS is increasingly being utilized for therapeutic interventions, such as targeted drug delivery, cyst drainage, and tumor ablation, broadening its clinical utility and driving market growth. The American Society for Gastrointestinal Endoscopy (ASGE) reported that EUS-guided interventions increased by 40% between 2019 and 2024, with procedures like cyst drainage and tumor ablation seeing the highest growth.

Global Endoscopy Ultrasound Market Regional Analysis

Here is a more detailed regional analysis of the global endoscopy ultrasound market:

North America

North America dominating the endoscopy ultrasound market due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a large pool of skilled professionals. According to the Centers for Disease Control and Prevention (CDC), gastrointestinal diseases affected approximately 70 million Americans in 2022, underscoring the growing need for advanced diagnostic and therapeutic tools like EUS.

The increasing prevalence of gastrointestinal diseases and robust healthcare expenditure further drive market growth in this region. The Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending reached USD 4.3 Trillion in 2024, with a notable portion allocated to advanced medical technologies like EUS. This substantial investment has facilitated the widespread adoption of cutting-edge EUS systems across healthcare institutions.

Government initiatives and funding for cancer research also contribute to the expanding use of EUS. For instance, in July 20, 2024, Pentax Medical, a key player in the EUS market, announced a partnership with a leading U.S. cancer research institute to develop a novel EUS-guided drug delivery system for pancreatic cancer treatment. This collaboration exemplifies the ongoing efforts to leverage EUS technology in advancing cancer care and solidifies North America's position at the forefront of EUS market growth.

Asia Pacific

The Asia-Pacific region is witnessing rapid growth in the endoscopic ultrasound (EUS) market, driven by substantial healthcare investments and an increasing prevalence of gastrointestinal disorders. According to the World Health Organization (WHO), healthcare spending in the Western Pacific region, which includes much of Asia, reached 6.6% of GDP in 2022, marking a significant increase from previous years.

This rising investment has directly contributed to improving healthcare infrastructure and the adoption of advanced medical technologies like EUS. The Asian Pacific Society for Digestive Endoscopy reported a 45% increase in EUS procedures across the region from 2020 to 2024, highlighting the growing acceptance and utilization of this technology.

China, Japan, and India are spearheading the expansion of the EUS market in the Asia-Pacific region. China's National Health Commission reported that the country's healthcare expenditure reached 7.12 trillion yuan (approximately USD 1.1 Trillion) in 2024, with a substantial portion allocated to upgrading medical equipment in hospitals.

The growing middle-class population and rising disposable incomes in the Asia-Pacific region are fueling the demand for advanced medical diagnostics and treatments. The Asian Development Bank estimated that 65% of the region's population will be middle class by 2025, up from 45% in 2015. This demographic shift has led to increased healthcare awareness and willingness to invest in advanced medical procedures.

Global Endoscopy Ultrasound Market: Segmentation Analysis

The Global Endoscopy Ultrasound Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

Based on Product Type, the Global Endoscopy Ultrasound Market is bifurcated into Radial-Endoscopic Ultrasound (EUS), Linear-Endoscopic Ultrasound (EUS), Curvilinear-Endoscopic Ultrasound (EUS), Phased Array-Endoscopic Ultrasound (EUS), and Doppler-Endoscopic Ultrasound (EUS). In the endoscopy ultrasound (EUS) market, linear-endoscopic ultrasound (EUS) is currently the dominant product type due to its widespread use in gastrointestinal diagnostics, providing detailed images for precise assessments of digestive tract conditions. Radial-endoscopic ultrasound (EUS) is the second rapidly growing segment, driven by its ability to offer comprehensive views of the surrounding structures, making it increasingly popular for evaluating pancreatic and bile duct conditions. Both product types are essential for enhancing diagnostic accuracy and are witnessing growth due to advancements in technology and increasing clinical applications.

Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

Based on Application, the Global Endoscopy Ultrasound Market is bifurcated into Gastroenterology, Oncology, Pulmonology, Gynecology, and Urology. In the endoscopy ultrasound (EUS) market, gastroenterology is the dominant application due to its extensive use in diagnosing and managing gastrointestinal conditions, such as cancers, pancreatitis, and bile duct abnormalities. Oncology is the second rapidly growing application, driven by the increasing need for precise staging and diagnosis of cancers, particularly in organs such as the pancreas and rectum, where EUS provides critical imaging for effective treatment planning and monitoring. Both applications are crucial in advancing diagnostic capabilities and improving patient outcomes in their respective fields.

Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

Based on End-User, the Global Endoscopy Ultrasound Market is bifurcated into Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Centers, and Clinics. In the endoscopy ultrasound (EUS) market, hospitals are the dominant end-user due to their comprehensive facilities and high volume of diagnostic and therapeutic procedures, which leverage EUS technology for advanced patient care. Ambulatory Surgical Centers (ASCs) are the second rapidly growing end-user, driven by the increasing preference for outpatient procedures and the need for minimally invasive diagnostics and treatments. ASCs offer a convenient and cost-effective setting for EUS procedures, contributing to their expanding role in the market.

Endoscopy Ultrasound Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Endoscopy Ultrasound Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the endoscopy ultrasound (EUS) market, North America is the dominant region, driven by its advanced healthcare infrastructure, high adoption of innovative medical technologies, and substantial healthcare expenditure. Asia-Pacific is the second rapidly growing region, fueled by increasing healthcare investments, rising prevalence of gastrointestinal disorders, and expanding healthcare infrastructure in countries like China, Japan, and India. The rapid growth in Asia-Pacific is supported by a rising middle-class population and greater accessibility to advanced medical diagnostics.

Key Players

The "Global Endoscopy Ultrasound Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Olympus Corporation, PENTAX Medical (HOYA Corporation), FUJIFILM Corporation, Hitachi Medical Systems, Boston Scientific Corporation, Cook Medical, Medtronic, CONMED Corporation, Medi-Globe GmbH, Limaca Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Endoscopy Ultrasound Market Key Developments

• In September 2024, Olympus Corporation introduced the UEV-400, a next-generation endoscopic ultrasound system featuring enhanced imaging resolution and real-time 3D visualization capabilities, aimed at improving diagnostic accuracy in gastrointestinal procedures.
• In June 2024, Fujifilm unveiled the EG-740UT, a new endoscopic ultrasound device with advanced needle guidance technology, designed to facilitate more precise biopsies and reduce procedure time in oncology applications.
• In March 2024, Pentax Medical announced a major upgrade to its EUS system with the release of the i-scan 3D, which integrates artificial intelligence to enhance image clarity and assist in the early detection of abnormalities.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

5. Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

6. Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Olympus Corporation
• PENTAX Medical (HOYA Corporation)
• FUJIFILM Corporation
• Hitachi Medical Systems
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References